 |
| |
|
Part 6. Nutrition And Phosphorus
|
Cost-Effective Nutritional Supplementation
Linda McCann, RD, CSR |
Sources of Hidden Phosphorus
Richard A. Sherman, MD |
Conference Closing Remarks
Madhukar Misra, MD |
| |
|
Part 5. Rationale Of Progressive Start, And Update On KDOQI Adequacy Guidelines
|
A/V Access In The Elderly
Surendra Shenoy, MD |
Treatment Of Complicated Access Patients: Aneurysms, Imminent Rupture, Acute/Chronic Thrombosed And Steal Syndrome
Christe Gooden, MD |
Managing Your Most Challenging Patient: Ask The Surgeon
Drs. Shenoy, and Gooden |
| |
|
Part 4. Rationale Of Progressive Start, And Update On KDOQI Adequacy Guidelines
|
Progressive Start: Evidence And Rationale
John T. Daugirdas, MD |
Progressive Start and Its Impact On Residual Renal Function
Kam Kalantar-Zadeh, MD |
KDOQI Adequacy Guidelines Update
Thomas Depner, MD |
| |
|
Part 3. Vascular Access and Home Hemodialysis Resources
|
Cannulation: Rescuing a lost Art
Robert Inman, MSN |
Home Hemodialysis Toolkit: Practical Uses
Christopher T. Chan, MD |
Home Hemodialysis Machines: A Practical Demonstration
Robert S. Lockridge, MD |
Frequent Hemodialysis And Outcomes In The Nursing Home Setting
Christopher T. Chan, MD |
| |
|
Part 2. Potassium in Hemodialysis: New Frontiers, and Vascular Access
|
Optimizing Dialysate Potassium
David Mendelssohn, MD |
Novel Potassium Binding Compounds
Stephen R. Ash, MD |
Cvc Simulation: Inserting Central Venous Catheters
Jeffrey H. Barsuk, MD |
| |
|
Part 1. Novel Therapeutic Protocols and Diagnostic Techniques in Dialysis Patients
|
Welcome Remarks
Madhukar Misra, MD (Course Director) |
Best Protocols for restoring flow in Venous Catheters
Haimanot Wasse, MD |
Platelet Aggregation Inhibitors and Anticoagulants in Dialysis
Tushar Vacharajani, MD |
Cardiac Arrhythmias in Dialysis Patients: Lessons from
the monitoring in Dialysis (Mid) Study
Prabir Roy-Chaudhury, MD |
Access to these talks requires membership-at-large in the ISHD or
key zone status at HDCN.
 |
Madhukar Misra, MD (Course Director)
Professor of Medicine, Division of Nephrology
University of Missouri School of Medicine
Health Sciences Center
Columbia, Missouri, USA
John T. Daugirdas, MD (Course Director)
Clinical Professor of Medicine
University of Illinois at Chicago School of Medicine
Chicago, Illinois. USA
Haimanot Wasse, MD
Director, Interventional Nephrology
Associate Professor in Medicine
Division of Nephrology/Hypertension
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Tushar Vacharajani, MD,
Section Chief, Nephrology
W.G. (Bill) Hefner VA Medical Center
Salisbury, North Carolina
Prabir Roy Chaudhury, MD
Chief, Division of Nephrology
Professor, Medicine
Department of Medicine
University of Arizona College of Medicine - Tucson
Tucson, Arizona
David Mendelssohn, MD
Humber River Regional Hospital
Division of Nephrology
Weston, Ontario
Stephen R. Ash, MD
Indiana University Health Arnett
HemoCleanse, Inc. and
Ash Access Technology, Inc.
Lafayette, Indiana
Jeffrey H. Barsuk, MD
Associate Professor in Medicine
Hospital Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Robert Inman, MSN, RN, CNN
Vascular Access Manager
Renal Associates P.A.
San Antonio, Texas
Christopher T. Chan, MD
Director, Division of Nephrology
University Health Network
R Fraser Elliot Chair in Home Dialysis
Professor of Medicine
University of Toronto, Canada
Robert S. Lockridge, Jr., MD
Lynchburg Nephrology
Clinical Assistant Professor
University of Virginia (UVA) Department of Medicine
Medical Director, UVA Home Dialysis Program
Lynchburg, Virginia
Tom A. Depner, MD
Professor of Internal Medicine and Nephrology
University of California, Davis
Lawrence J. Ellison Ambulatory Care Center
Nephrology Clinic
Sacramento, California
Surendra Shenoy, MD
Associate Professor, Surgery
Division of General Surgery
Section of Transplantation Surgery
Washington University School of Medicine
St. Louis, Missouri
Christie Gooden, MD
Surgical Director, Kidney Transplant Program and
Director, Dialysis Access Center
Saint Luke’s Hospital
Kansas City, Missouri
Linda McCann, RN, CSR
Renal Dietitian
Satellite Healthcare, Inc.
San Jose, California
Richard A. Sherman, MD
Department of Medicine, Nephrology Division
Rutgers University and Professor of Medicine, Dialysis Program
Robert Wood Johnson University Hospital and Saint Peters University Hospital
New Brunswick, New Jersey
Kam Kalantar-Zadeh, MD
Chief, Division of Nephrology & Hypertension
Professor of Medicine, Pediatrics and Public Health
University of California, Irvine
Adjunct Professor of Epidemiology
UCLA Fielding School of Public Health
Orange, California |
|
 |
This educational activity is an audio recording with accompanying slides of a live presentation
held on October 2 - 3, 2015, in Chicago, Illinois, USA. Continuing medical education credit is not available for this on-line archive.
To view this educational activity, the user will need Windows (XP or higher) or
Macintosh (version 9.0 or higher) operating software, a connection to the internet with a
28.8 kbps MODEM or better. The computer should have an audio card with speakers.
An audio player is required and either can be downloaded for free per instructions on the individual lecture pages.
Flash 8.0 (from www.adobe.com) is useful but not necessary to see the full-screen slide/audio presentations and the video presentations.
Acrobat Reader is required to print the slide handouts.
Program Overview
Target Audience
The conference is designed for health professionals involved in dialysis programs, primarily nephrologists, nephrology fellows, nephrology nurses and nurse practitioners, and patient care technicians.
| SPEAKER DISCLOSURE STATEMENT and OFF-LABEL USE: |
Disclosure Policy
It is the policy of the ISHD and HDCN that speakers with potential conflicts of interest disclose these at the time of presentation.
Off-label/lnvestigational Use
Because this course is meant to educate physicians with what is currently in use and what may be
available in the future, there may be "off-label" use discussed in the presentations. Speakers have
been requested to inform the audience when off-label use is being discussed.
The policy statements of HDCN are listed on this page.
|
|
